Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Wave Life Sciences Ltd. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
WVE
Nasdaq
2830
wavelifesciences.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Wave Life Sciences Ltd.
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
- Jun 24th, 2026 6:30 am
Wave Life Sciences (WVE) Upgraded to Buy: Here's Why
- Jun 16th, 2026 10:00 am
Strength Seen in Intellia Therapeutics (NTLA): Can Its 23.2% Jump Turn into More Strength?
- Jun 16th, 2026 6:43 am
Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now?
- Jun 13th, 2026 2:45 pm
Wave Life Sciences to Present at Upcoming Investor Conferences
- Jun 1st, 2026 6:30 am
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter
- May 31st, 2026 2:16 pm
Should WVE-006’s RNA-Editing AAT Data Shift the Risk-Reward Calculus for Wave Life Sciences (WVE) Investors?
- May 25th, 2026 5:13 am
Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update
- May 20th, 2026 4:43 am
Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1
- May 19th, 2026 7:49 am
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
- May 18th, 2026 2:30 pm
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
- May 13th, 2026 2:05 pm
Growth Investors: Industry Analysts Just Upgraded Their Wave Life Sciences Ltd. (NASDAQ:WVE) Revenue Forecasts By 91%
- May 8th, 2026 7:41 am
A Look At Wave Life Sciences (WVE) Valuation After Sharp Year To Date Share Price Decline
- May 2nd, 2026 6:17 pm
Arrowhead (ARWR) Rated Buy on Metabolic Pipeline Potential
- May 2nd, 2026 11:51 am
Wave Life Sciences Ltd. Q1 2026 Earnings Call Summary
- Apr 29th, 2026 6:30 am
WAVE Life Sciences Ltd (WVE) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...
- Apr 29th, 2026 1:05 am
WAVE Life Sciences Q1 Earnings Call Highlights
- Apr 28th, 2026 1:23 pm
Wave Life Sciences (WVE) Reports Q1 Loss, Beats Revenue Estimates
- Apr 28th, 2026 6:45 am
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
- Apr 28th, 2026 5:30 am
Wave Life Sciences Ltd. (WVE) Sees Strong Buy Rating From Analysts
- Apr 22nd, 2026 8:23 am
Scroll